Medical network - December 10, 2016, Chinese herbal medicine price rise caused the attention of the society as a whole.
Zhuo chong, an analyst zhang said in an interview with "securities daily", "since 2013, the price of traditional Chinese medicine has been in the doldrums. 2016, influenced by multiple factors, overall prices for Chinese herbal medicine." According to the statistics, nearly a month, including platycodon grandiflorum, sichuan dome, atractylodes, varieties of Chinese medicinal materials rises greatly.
"Chinese medicinal materials rise in price, and the demand to support production, weather factors, farmers in weight loss." Zhang believes that some varieties prices associated with artificial pressure of stock speculation also exist.
However, one in the industry told reporters that traditional Chinese medicinal materials quality will become a big trend. The supervision department of the state of traditional Chinese medicine flight inspections, so as to make the inferior Chinese herbal medicine to reduce delivery, reduce market supply, make the high quality of Chinese medicinal materials prices are going.
Chinese herbal medicine prices
Since this year, according to sig Chinese medicinal herbs, price index, Chinese herbal medicine price index rose as a whole. Since July this year, Chinese herbal medicine price index rose faster.
Data show that some varieties of Chinese medicinal materials price has more than doubled this year. Notoginseng, for example, 40 producer prices earlier this year of about 200 yuan/kg, has recently rose to 390 yuan/kg to 400 yuan/kg, rise up to 100%; Fructus schisandrae earlier this year the price of about 53 yuan/kg, has recently rose to 140 yuan/kg, 164%; Dangshen earlier this year the price of about 30 yuan/kg (price) of origin, in August, prices rise, up to 67.8 yuan/kg, 126%.
Chinese herbal medicine price rise caused the social attention.
The state council information office on December 6, to publish a white paper on "China's traditional Chinese medicine", the development of Chinese medicine and the white paper are introduced. At a news conference, Chinese herbal medicine prices become the focus.
For the matter, the national health development planning commission, deputy director of the state administration of traditional Chinese medicine guo-qiang wang responded that the rising price of Chinese medicinal materials is an objective fact, but to correctly and objectively view: "one, the price of Chinese medicinal materials, the past has been on the low side, despite the fact that Chinese agricultural products, but in agricultural products, Chinese herbal medicine has not the adjustment of price. This situation directly affect the enthusiasm of herbalist planting medicinal materials. 2, no reasonable price formation mechanism, makes the quality of Chinese herbal medicine planting also be affected. So, adjust the price of Chinese medicinal materials, it is necessary, also is development important aspect for the sustainable development of traditional Chinese medicine".
Guo-qiang wang also said that about Chinese herbal medicine prices cause, especially the rise in some precious, rare medicinal materials, it is a reality. On the one hand, to vigorously promote the standardized cultivation of Chinese medicinal materials, development, make traditional Chinese medicine (TCM) can form scale on the basis of improving quality, ensure the supply, this aspect is very important. On the other hand, to build a reasonable price adjustment mechanism, some is the appropriate increase in price, but medicinal materials production, prices will fall.
, zhuo chong, an analyst zhang bin to the "securities daily" reporters, overall Chinese herbal medicine prices, in addition to the impact of the change of supply and demand, tighter national policy also indirectly makes the whole traditional Chinese medicine prices. In recent years, regulators stepped up to flight inspections of Chinese herbal medicine market, and this makes it hard for some bad products into the market, and some Chinese herbal medicine processing, extraction enterprises also gradually improve the process, making a rise in the cost.
Benefit of listed companies is different
Chinese medicinal materials rise in price, the related listed companies will also impact of business.
Jin yi investment strategy analyst Yuan Wenyang to the "securities daily" reporters that should be from two aspects to see the influence of Chinese traditional medicine prices of listed companies. "On the one hand, Chinese herbal medicine price increases for Chinese herbal medicine raw materials management companies, including Chinese herbal medicine raw materials plant layout, and the upstream and downstream industry chain to perfect the related listed companies, the company will directly benefit from the dividends of Chinese medicinal materials price increases. On the other hand, Chinese traditional medicine is raw material demand prices relatively bad in the middle and lower reaches of the listed company, the company will face a Chinese herbal medicine raw material cost increase of operating pressure. Of course, from the transmission between cost and price have a certain amount of time effect, many companies may choose to raise prices to hedge raw materials prices."
For the change of the Chinese herbal medicine price, traditional Chinese medicine (TCM), including sig pharmaceutical, guizhou lark, save for a rainy day of listed companies, select self-built plant base.
Related people in guizhou lark said in an interview, in the case of Chinese medicinal materials prices, the company will strengthen the control of purchasing cost management, on the premise of to ensure the quality of medicinal materials of raw materials, through the analysis of the change of supply and demand, forecasting the price trend, effectively reduce the purchase price; Continuous innovation and improvement on procurement mode, actively with suppliers to establish long-term good relations of cooperation, can effectively implement the cost management work; Along with acquisition of self-built plant base or region, close relation between production and marketing, expand sourcing channels.
Guizhou lark these people also, the company has in guizhou zhenning, information, ziyun and so on, establish mountain yinhua, lucky grass, saxifrage, lamps and so on a variety of more than 20 Chinese herbal medicine planting base of ten thousand mu, to a certain extent provides raw materials with good quality for the company, further to control costs. |
